IDEAS home Printed from https://ideas.repec.org/r/eee/soceps/v10y1976i3p129-136.html
   My bibliography  Save this item

Social preferences for health states: An empirical evaluation of three measurement techniques

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Heather J. Sutherland & Hilary Llewellyn-Thomas & Norman F. Boyd & James E. Till, 1982. "Attitudes Toward Quality of Survival," Medical Decision Making, , vol. 2(3), pages 299-309, August.
  2. H. Llewellyn-Thomas & H.J. Sutherland & R. Tibshirani & A. Ciampi & J.E. Till & N.F. Boyd, 1982. "The Measurement of Patients' Values in Medicine," Medical Decision Making, , vol. 2(4), pages 449-462, December.
  3. Peter A. Ubel & George Loewenstein & Dennis Scanlon & Mark Kamlet, 1996. "Individual Utilities Are Inconsistent with Rationing Choices," Medical Decision Making, , vol. 16(2), pages 108-116, June.
  4. June F. O'Leary & Diane L. Fairclough & M. Kay Jankowski & Jane C. Weeks, 1995. "Comparison of Time-tradeoff Utilities and Rating Scale Values of Cancer Patients and Their Relatives," Medical Decision Making, , vol. 15(2), pages 132-137, June.
  5. Craig., Benjamin M. & Busschbach, Jan J.V., 2011. "Revisiting United States valuation of EQ-5D states," Journal of Health Economics, Elsevier, vol. 30(5), pages 1057-1063.
  6. John Vernon & Robert Goldberg & Joseph Golec, 2009. "Economic Evaluation and Cost-Effectiveness Thresholds," PharmacoEconomics, Springer, vol. 27(10), pages 797-806, October.
  7. Zeynep Erkin & Matthew D. Bailey & Lisa M. Maillart & Andrew J. Schaefer & Mark S. Roberts, 2010. "Eliciting Patients' Revealed Preferences: An Inverse Markov Decision Process Approach," Decision Analysis, INFORMS, vol. 7(4), pages 358-365, December.
  8. P. Stalmeier & A. Verheijen, 2013. "Maximal endurable time states and the standard gamble: more preference reversals," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(6), pages 971-977, December.
  9. Katherine J. Stevens & Christopher J. McCabe & John E. Brazier, 2006. "Mapping between Visual Analogue Scale and Standard Gamble data; results from the UK Health Utilities Index 2 valuation survey," Health Economics, John Wiley & Sons, Ltd., vol. 15(5), pages 527-533, May.
  10. Ivana Unic & Peep F.M. Stalmeier & Lia C.G. Verhoef & Willem A.J. Van Daal, 1998. "Assessment of the Time-tradeoff Val ues for Prophylactic Mastectomy of Women with a Suspected Genetic Predisposition to Breast Cancer," Medical Decision Making, , vol. 18(3), pages 268-277, August.
  11. Bruno Casal & Eva Rodríguez-Míguez & Berta Rivera, 2020. "Measuring intangible cost-of-morbidity due to substance dependence: implications of using alternative preference-based instruments," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(7), pages 1039-1048, September.
  12. Hilary A. Llewellyn-Thomas & J. Ivan Williams & Linda Levy & C.D. Naylor, 1996. "Using a Trade-off Technique to Assess Patients' Treatment Preferences for Benign Prostatic Hyperplasia," Medical Decision Making, , vol. 16(3), pages 262-272, August.
  13. Julie Ratcliffe & Gang Chen & Katherine Stevens & Sandra Bradley & Leah Couzner & John Brazier & Michael Sawyer & Rachel Roberts & Elisabeth Huynh & Terry Flynn, 2015. "Valuing Child Health Utility 9D Health States with Young Adults: Insights from a Time Trade Off Study," Applied Health Economics and Health Policy, Springer, vol. 13(5), pages 485-492, October.
  14. Hilary A. Llewellyn-Thomas & Elaine C. Thiel & M. June McGreal, 1992. "Cancer Patients' Evaluations of Their Current Health State," Medical Decision Making, , vol. 12(2), pages 115-122, June.
  15. Suzanne Robinson, 2011. "Test–retest reliability of health state valuation techniques: the time trade off and person trade off," Health Economics, John Wiley & Sons, Ltd., vol. 20(11), pages 1379-1391, November.
  16. Milton C. Weinstein, 1981. "Economic Assessments of Medical Practices and Technologies," Medical Decision Making, , vol. 1(4), pages 309-330, December.
  17. Gretchen B. Chapman & Arthur S. Elstein & Timothy M. Kuzel & Roohollah Sharifi & Robert B. Nadler & Anita Andrews & Charles L. Bennett, 1998. "Prostate Cancer Patients' Utilities for Health States," Medical Decision Making, , vol. 18(3), pages 278-286, August.
  18. F. E. van Nooten & X. Koolman & W. B. F. Brouwer, 2009. "The influence of subjective life expectancy on health state valuations using a 10 year TTO," Health Economics, John Wiley & Sons, Ltd., vol. 18(5), pages 549-558, May.
  19. Norman F. Boyd & Heather J. Sutherland & Karen Z. Heasman & David L. Tritchler & Bernard J. Cummings, 1990. "Whose Utilities for Decision Analysis?," Medical Decision Making, , vol. 10(1), pages 58-67, February.
  20. Paul F. M. Krabbe & Elly A. Stolk & Nancy J. Devlin & Feng Xie & Elise H. Quik & A. Simon Pickard, 2017. "Head-to-head comparison of health-state values derived by a probabilistic choice model and scores on a visual analogue scale," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(8), pages 967-977, November.
  21. Paula K. Lorgelly & Kenny D. Lawson & Elisabeth A.L. Fenwick & Andrew H. Briggs, 2010. "Outcome Measurement in Economic Evaluations of Public Health Interventions: a Role for the Capability Approach?," IJERPH, MDPI, vol. 7(5), pages 1-16, May.
  22. Donald A. Redelmeier & Daniel N. Heller, 1993. "Time Preference in Medical Decision Making and Cost - Effectiveness Analysis," Medical Decision Making, , vol. 13(3), pages 212-217, August.
  23. A.M. Stiggelbout & G.M. Kiebert & J. Kievit & J.W.H. Leer & G. Stoter & J.C.J.M. De Haes, 1994. "Utility Assessment in Cancer Patients," Medical Decision Making, , vol. 14(1), pages 82-90, February.
  24. A. David Paltiel & Julie A. Scharfstein & George R. Seage & Elena Losina & Sue J. Goldie & Milton C. Weinstein & Donald E. Craven & Kenneth A. Freedberg, 1998. "A Monte Carlo Simulation of Advanced HIV Disease," Medical Decision Making, , vol. 18(2_suppl), pages 93-105, April.
  25. Ann M. Holmes, 1997. "A Method to Elicit Utilities for Interpersonal Comparisons," Medical Decision Making, , vol. 17(1), pages 10-20, February.
  26. Bas Janssen & Mark Oppe & Matthijs Versteegh & Elly Stolk, 2013. "Introducing the composite time trade-off: a test of feasibility and face validity," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(1), pages 5-13, July.
  27. Angela Robinson & Graham Loomes & Michael Jones-Lee, 2001. "Visual Analog Scales, Standard Gambles, and Relative Risk Aversion," Medical Decision Making, , vol. 21(1), pages 17-27, February.
  28. Linda A. Merlino & Indranil Bagchi & Thomas N. Taylor & Paul Utrie & Elizabeth Chrischilles & Walton Sumner II & Amy Mudano & Kenneth G. Saag, 2001. "Preferences for Fractures and Other Glucocorticoid-Associated Adverse Effects among Rheumatoid Arthritis Patients," Medical Decision Making, , vol. 21(2), pages 122-132, April.
  29. Arne Risa Hole & Richard Norman & Rosalie Viney, 2016. "Response Patterns in Health State Valuation Using Endogenous Attribute Attendance and Latent Class Analysis," Health Economics, John Wiley & Sons, Ltd., vol. 25(2), pages 212-224, February.
  30. Louis S. Matza & Kristina S. Boye & David H. Feeny & Lee Bowman & Joseph A. Johnston & Katie D. Stewart & Kelly McDaniel & Jessica Jordan, 2016. "The time horizon matters: results of an exploratory study varying the timeframe in time trade-off and standard gamble utility elicitation," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(8), pages 979-990, November.
  31. Benjamin Matthew Craig & Kim Rand & John D. Hartman, 2022. "Preference Paths and Their Kaizen Tasks for Small Samples," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 15(2), pages 187-196, March.
  32. Julie Ratcliffe & John Brazier & Aki Tsuchiya & Tara Symonds & Martin Brown, 2009. "Using DCE and ranking data to estimate cardinal values for health states for deriving a preference‐based single index from the sexual quality of life questionnaire," Health Economics, John Wiley & Sons, Ltd., vol. 18(11), pages 1261-1276, November.
  33. Michael Wolfson, 2011. "Health Care is a Knowledge Industry, and Should Be More So," New Directions for Intelligent Government in Canada: Papers in Honour of Ian Stewart, in: Fred Gorbet & Andrew Sharpe (ed.),New Directions for Intelligent Government in Canada: Papers in Honour of Ian Stewart, pages 249-282, Centre for the Study of Living Standards.
  34. Peter Franks & Erica I. Lubetkin & Joy Melnikow, 2007. "Do personal and societal preferences differ by socio‐demographic group?," Health Economics, John Wiley & Sons, Ltd., vol. 16(3), pages 319-325, March.
  35. J. Leighton Read & Robert J. Quinn & Donald M. Berwick & Harvey V. Fineberg & Milton C. Weinstein, 1984. "Preferences for Health Outcomes," Medical Decision Making, , vol. 4(3), pages 315-329, August.
  36. Marisa Santos & Monica A. C. T. Cintra & Andrea L. Monteiro & Braulio Santos & Fernando Gusmão-filho & Mônica Viegas Andrade & Kenya Noronha & Luciane N. Cruz & Suzi Camey & Bernardo Tura & Paul Kin, 2016. "Brazilian Valuation of EQ-5D-3L Health States," Medical Decision Making, , vol. 36(2), pages 253-263, February.
  37. Bleichrodt, Han & Johannesson, Magnus, 1997. "Standard gamble, time trade-off and rating scale: Experimental results on the ranking properties of QALYs," Journal of Health Economics, Elsevier, vol. 16(2), pages 155-175, April.
  38. Peter A. Ubel & George Loewenstein, 2008. "Pain and Suffering Awards: They Shouldn't Be (Just) about Pain and Suffering," The Journal of Legal Studies, University of Chicago Press, vol. 37(S2), pages 195-216, June.
  39. Paul F.M. Krabbe & Marie-Louise Essink-Bot & Gouke J. Bonsel, 1996. "On the Equivalence of Collectively and Individually Collected Responses," Medical Decision Making, , vol. 16(2), pages 120-132, June.
  40. Hilary A. Llewellyn-Thomas & J. Michael Paterson & Judy A. Carter & Antoni Basinski & Martin G. Myers & Gordon D. Hardacre & Earl V. Dunn & Ralph B. D’Agostino & Philip A. Wolf & C. David Naylor, 2002. "Primary Prevention Drug Therapy: Can It Meet Patients’ Requirements for Reduced Risk?," Medical Decision Making, , vol. 22(4), pages 326-339, August.
  41. Julie Ratcliffe & Terry Flynn & Frances Terlich & Katherine Stevens & John Brazier & Michael Sawyer, 2012. "Developing Adolescent-Specific Health State Values for Economic Evaluation," PharmacoEconomics, Springer, vol. 30(8), pages 713-727, August.
  42. Marie-Josée Dion & Pierre Tousignant & Jean Bourbeau & Dick Menzies & Kevin Schwartzman, 2002. "Measurement of Health Preferences among Patients with Tuberculous Infection and Disease," Medical Decision Making, , vol. 22(1_suppl), pages 102-114, September.
  43. Dolan, Paul & Jones-Lee, Michael, 1997. "The time trade-off: A note on the effect of lifetime reallocation of consumption and discounting," Journal of Health Economics, Elsevier, vol. 16(6), pages 731-739, December.
  44. Dolan, P. & Gudex, C. & Kind, P. & Williams, A., 1996. "Valuing health states: A comparison of methods," Journal of Health Economics, Elsevier, vol. 15(2), pages 209-231, April.
  45. Ann E. Clarke, 1997. "Arthritis Patient Education: How Economic Evaluations Can Inform Health Policy," Canadian Public Policy, University of Toronto Press, vol. 23(s1), pages 162-176, Spring.
  46. Carol A.E. Nickerson, 1999. "Assessing Convergent Validity of Health-state Utilities Obtained Using Different Scaling Methods," Medical Decision Making, , vol. 19(4), pages 487-498, October.
  47. Peter Hertzman, 2005. "The cost effectiveness of orlistat in a 1-year weight-management programme for treating overweight and obese patients in Sweden," PharmacoEconomics, Springer, vol. 23(10), pages 1007-1020, October.
  48. Jennifer Whitty & Sharyn Rundle-Thiele & Paul Scuffham, 2012. "Insights from triangulation of two purchase choice elicitation methods to predict social decision making in healthcare," Applied Health Economics and Health Policy, Springer, vol. 10(2), pages 113-126, March.
  49. Raisa B. Deber & Vivek Goel, 1990. "Using Explicit Decision Rules to Manage Issues of Justice, Risk, and Ethics in Decision Analysis," Medical Decision Making, , vol. 10(3), pages 181-194, August.
  50. Paul F M Krabbe, 2013. "A Generalized Measurement Model to Quantify Health: The Multi-Attribute Preference Response Model," PLOS ONE, Public Library of Science, vol. 8(11), pages 1-12, November.
  51. Eric B. Bass & Earl P. Steinberg & Henry A. Pitt & Robert I. Griffiths & Keith D. Lillemoe & George P. Saba & Christina Johns, 1994. "Comparison of the Rating Scale and the Standard Gamble in Measuring Patient Preferences for Outcomes of Gallstone Disease," Medical Decision Making, , vol. 14(4), pages 307-314, October.
  52. Paul Dolan & Claire Gudex, 1995. "Time preference, duration and health state valuations," Health Economics, John Wiley & Sons, Ltd., vol. 4(4), pages 289-299, July.
  53. Levy, Moshe & Nir, Adi Rizansky, 2012. "The utility of health and wealth," Journal of Health Economics, Elsevier, vol. 31(2), pages 379-392.
  54. Lena Lundberg & Magnus Johannesson & Dag G.L. Isacson & Lars Borgquist, 1999. "The Relationship between Health-state Utilities and the SF-12 in a General Population," Medical Decision Making, , vol. 19(2), pages 128-140, April.
  55. Jason N. Doctor & Han Bleichrodt & H. Jill Lin, 2010. "Health Utility Bias: A Systematic Review and Meta-Analytic Evaluation," Medical Decision Making, , vol. 30(1), pages 58-67, January.
  56. Alan Williams, 1995. "A measurement and validation of health: a chronicle," Working Papers 136chedp, Centre for Health Economics, University of York.
  57. Diego Ossa & Andrew Briggs & Emma McIntosh & Warren Cowell & Tim Littlewood & Mark Sculpher, 2007. "Recombinant Erythropoietin for Chemotherapy-Related Anaemia," PharmacoEconomics, Springer, vol. 25(3), pages 223-237, March.
  58. Xavier Badia & Montserrat Roset & Michael Herdman & Paul Kind, 2001. "A Comparison of United Kingdom and Spanish General Population Time Trade-off Values for EQ-5D Health States," Medical Decision Making, , vol. 21(1), pages 7-16, February.
  59. Holger J. Schünemann & Lauren Griffith & David Stubbing & Roger Goldstein & Gordon H. Guyatt, 2003. "A Clinical Trial to Evaluate the Measurement Properties of 2 Direct Preference Instruments Administered with and without Hypothetical Marker States," Medical Decision Making, , vol. 23(2), pages 140-149, March.
  60. Peter E. Krumins & Stephan D. Fihn & Daniel L. Kent, 1988. "Symptom Severity and Patients' Values in the Decision to Perform a Transurethral Resection of the Prostate," Medical Decision Making, , vol. 8(1), pages 1-8, February.
  61. Elena B. Elkin & Mark E. Cowen & Daniel Cahill & Mary Steffel & Michael W. Kattan, 2004. "Preference Assessment Method Affects Decision-Analytic Recommendations: A Prostate Cancer Treatment Example," Medical Decision Making, , vol. 24(5), pages 504-510, October.
  62. A. David Paltiel & Kenneth A. Freedberg, 1998. "The Cost-Effectiveness of Preventing Cytomegalovirus Disease in AIDS Patients," Interfaces, INFORMS, vol. 28(3), pages 34-51, June.
  63. G. Anderson & C. Bombardier, 1984. "Estimating Disease Activity in Rheumatoid Arthritis," Medical Decision Making, , vol. 4(4), pages 469-487, December.
  64. Robert J. Brent, 2012. "The Effects Of Hiv Medications On The Quality Of Life Of Older Adults In New York City," Health Economics, John Wiley & Sons, Ltd., vol. 21(8), pages 967-976, August.
  65. Denise Bijlenga & Gouke J. Bonsel & Erwin Birnie, 2011. "Eliciting willingness to pay in obstetrics: comparing a direct and an indirect valuation method for complex health outcomes," Health Economics, John Wiley & Sons, Ltd., vol. 20(11), pages 1392-1406, November.
  66. Heather J. Sutherland & Virginia Dunn & Norman F. Boyd, 1983. "Measurement of Values for States of Health with Linear Analog Scales," Medical Decision Making, , vol. 3(4), pages 477-487, December.
  67. Claire Gudex & Paul Kind & Harmanna van Dalen & Mary-Alison Durand & Jenny Morris & Alan Williams, 1993. "Comparing scaling methods for health state valuations - Rosser revisited," Working Papers 107chedp, Centre for Health Economics, University of York.
  68. George W. Torrance & David Feeny & William Furlong, 2001. "Visual Analog Scales," Medical Decision Making, , vol. 21(4), pages 329-334, August.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.